327 related articles for article (PubMed ID: 32603415)
1. Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis.
Pieper NT; Grossi CM; Chan WY; Loke YK; Savva GM; Haroulis C; Steel N; Fox C; Maidment ID; Arthur AJ; Myint PK; Smith TO; Robinson L; Matthews FE; Brayne C; Richardson K
Age Ageing; 2020 Oct; 49(6):939-947. PubMed ID: 32603415
[TBL] [Abstract][Full Text] [Related]
2. Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.
Taylor-Rowan M; Kraia O; Kolliopoulou C; Noel-Storr AH; Alharthi AA; Cross AJ; Stewart C; Myint PK; McCleery J; Quinn TJ
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015196. PubMed ID: 35994403
[TBL] [Abstract][Full Text] [Related]
3. Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.
Taylor-Rowan M; Edwards S; Noel-Storr AH; McCleery J; Myint PK; Soiza R; Stewart C; Loke YK; Quinn TJ
Cochrane Database Syst Rev; 2021 May; 5(5):CD013540. PubMed ID: 34097766
[TBL] [Abstract][Full Text] [Related]
4. Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care.
Campbell NL; Lane KA; Gao S; Boustani MA; Unverzagt F
Pharmacotherapy; 2018 May; 38(5):511-519. PubMed ID: 29600808
[TBL] [Abstract][Full Text] [Related]
5. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
[TBL] [Abstract][Full Text] [Related]
6. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.
Carrière I; Fourrier-Reglat A; Dartigues JF; Rouaud O; Pasquier F; Ritchie K; Ancelin ML
Arch Intern Med; 2009 Jul; 169(14):1317-24. PubMed ID: 19636034
[TBL] [Abstract][Full Text] [Related]
7. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review.
Andre L; Gallini A; Montastruc F; Montastruc JL; Piau A; Lapeyre-Mestre M; Gardette V
Eur J Clin Pharmacol; 2019 Dec; 75(12):1631-1644. PubMed ID: 31468067
[TBL] [Abstract][Full Text] [Related]
8. Anticholinergic Drug Burden and Risk of Incident MCI and Dementia: A Population-based Study.
Gildengers A; Stoehr GP; Ran X; Jacobsen E; Teverovsky E; Chang CH; Ganguli M
Alzheimer Dis Assoc Disord; 2023 Jan-Mar 01; 37(1):20-27. PubMed ID: 36706325
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of incident dementia following use of anticholinergic agents: A systematic literature review and meta-analysis.
Dmochowski RR; Thai S; Iglay K; Enemchukwu E; Tee S; Varano S; Girman C; Radican L; Mudd PN; Poole C
Neurourol Urodyn; 2021 Jan; 40(1):28-37. PubMed ID: 33098213
[TBL] [Abstract][Full Text] [Related]
10. Anticholinergics and clinical outcomes amongst people with pre-existing dementia: A systematic review.
Wang K; Alan J; Page AT; Dimopoulos E; Etherton-Beer C
Maturitas; 2021 Sep; 151():1-14. PubMed ID: 34446273
[TBL] [Abstract][Full Text] [Related]
11. Cross-sectional and longitudinal associations between adherence to Mediterranean diet with physical performance and cognitive function in older adults: A systematic review and meta-analysis.
Coelho-Júnior HJ; Trichopoulou A; Panza F
Ageing Res Rev; 2021 Sep; 70():101395. PubMed ID: 34153553
[TBL] [Abstract][Full Text] [Related]
12. Increasing prevalence of anticholinergic medication use in older people in England over 20 years: cognitive function and ageing study I and II.
Grossi CM; Richardson K; Savva GM; Fox C; Arthur A; Loke YK; Steel N; Brayne C; Matthews FE; Robinson L; Myint PK; Maidment ID
BMC Geriatr; 2020 Jul; 20(1):267. PubMed ID: 32736640
[TBL] [Abstract][Full Text] [Related]
13. Anticholinergic Burden and Cognitive Impairment in Nursing Homes: A Comparison of Four Anticholinergic Scales.
Novella A; Elli C; Ianes A; Pasina L
Drugs Aging; 2023 Nov; 40(11):1017-1026. PubMed ID: 37620654
[TBL] [Abstract][Full Text] [Related]
14. Anticholinergic burden and risk of cognitive impairment in elderly nursing home residents with depression.
Chatterjee S; Bali V; Carnahan RM; Chen H; Johnson ML; Aparasu RR
Res Social Adm Pharm; 2020 Mar; 16(3):329-335. PubMed ID: 31182419
[TBL] [Abstract][Full Text] [Related]
15. Relation between anticholinergic burden and cognitive impairment: Results from the Monzino 80-plus population-based study.
Pasina L; Lucca U; Tettamanti M
Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1696-1702. PubMed ID: 33098318
[TBL] [Abstract][Full Text] [Related]
16. Associations Between Midlife Anticholinergic Medication Use and Subsequent Cognitive Decline: A British Birth Cohort Study.
Rawle MJ; Lau WCY; Gonzalez-Izquierdo A; Patalay P; Richards M; Davis D
Drugs Aging; 2024 Jun; 41(6):543-554. PubMed ID: 38740716
[TBL] [Abstract][Full Text] [Related]
17. Centrally-acting anticholinergic drugs- associations with mortality, hospitalisation and cognitive decline following dementia diagnosis in people receiving antidepressant and antipsychotic drugs.
Bishara D; Perera G; Harwood D; Taylor D; Sauer J; Funnell N; Gee S; Stewart R; Mueller C
Aging Ment Health; 2022 Sep; 26(9):1747-1755. PubMed ID: 34308718
[TBL] [Abstract][Full Text] [Related]
18. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study.
Gray SL; Anderson ML; Dublin S; Hanlon JT; Hubbard R; Walker R; Yu O; Crane PK; Larson EB
JAMA Intern Med; 2015 Mar; 175(3):401-7. PubMed ID: 25621434
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
